Located in:
Cham

Company:
AbbVie

AbbVie is a global, research-based biopharmaceuti­cal company focused on discovering and developing innovative therapies that treat some of the world‘s most serious and complex diseases. AbbVie’s goal is to improve people‘s lives. We focus on the following therapeutic areas: immunology, oncology, neurosci­ence, ophthalmology, virology and gastroenterology. The acquisition of Allergan brings together more than 30 leading brands and expands and diversifies the product portfolio.

Headquartered in Chicago, USA, AbbVie employs approximately 50,000 people worldwide. Around 57 million patients in more than 175 countries benefit from AbbVie medicines every year. In Switzerland, 250 employees work for AbbVie. In 2023, AbbVie Switzerland was named one of the best employers in the medium-sized company category by Great Place to Work^® Switzerland for the 9th time in a row.

More information at: AbbVie | Pharmaceutical Research & Development

Located in:
Schaffhausen

Company:
AbbVie

AbbVie is a global, research-based biopharmaceuti­cal company focused on discovering and developing innovative therapies that treat some of the world‘s most serious and complex diseases. AbbVie’s goal is to improve people‘s lives. We focus on the following therapeutic areas: immunology, oncology, neurosci­ence, ophthalmology, virology and gastroenterology. The acquisition of Allergan brings together more than 30 leading brands and expands and diversifies the product portfolio.

Headquartered in Chicago, USA, AbbVie employs approximately 50,000 people worldwide. Around 57 million patients in more than 175 countries benefit from AbbVie medicines every year. In Switzerland, 250 employees work for AbbVie. In 2023, AbbVie Switzerland was named one of the best employers in the medium-sized company category by Great Place to Work^® Switzerland for the 9th time in a row.

More information at: AbbVie | Pharmaceutical Research & Development

Located in:
Rotkreuz

Company:
Amgen

Amgen Inc., which is based in Thousand Oaks, Ca­lifornia, was founded in 1980 as Applied Molecular Genetics Inc. and is one of the pioneers of indust­rial biotechnology and is the world‘s largest inde­pendent biotechnology company with nearly 24,000 employees in nearly 100 countries.

In 1989, Amgen established its European headquarters in Switzerland – and in 2002 the Swiss subsidiary followed. Since 2018, the hub and the Swiss branch are in Rotkreuz. Amgen is committed to researching the latest biome­dical prospects for the benefit of patients with serious diseases. Using modern methods of gene technology, Amgen is working on deciphering the complexity of diseases and understanding the fundamental princip­les of human biology. Our drugs are used in nephro­logy, cardiology, hematology, oncology, bone health and chronic inflammatory diseases. In addition to ori­ginal preparations, our portfolio also includes biosimi­lars. We have a diverse pipeline.

More information at: Amgen

Located in:
Baar

Company:
AstraZeneca

AstraZeneca is a British pharmaceutical company and has been active in Switzerland for almost 50 years. The company is among the ten largest pharmaceutical firms in Switzerland and is involved in the following therapy areas: oncology, respiratory diseases and immunology, cardiovascular, renal and metabolic diseases, as well as vaccines and immunotherapy, which also includes medications to combat Covid 19. The primary aim of the over 250 staff members is to make new medicines available to patients as rapidly as possible. In Switzerland, more than 250,000 individuals are under treatment with an AstraZeneca medication. By 2025, the firm anticipates licensing over 35 new therapies. AstraZeneca is committed to the goal of making the Swiss health care system more sustainable and resilient. In order to honour its commitment to a healthy planet and a healthy population, the company is working tirelessly to reduce CO2 emissions and waste products. Thus, it has set a target for itself to come carbon-negative by 2030.

More information at: AstraZeneca Switzerland

Located in:
Basel

Company:
Bayer

Bayer is a Life Science company with a more than 150-year history. Our 101,000 employees are passionately committed to people’s health care and nutrition all over the world and push ahead with research, development and innovation in these areas. Contributing to sustainable development is a core element of Bayer’s strategy and values. Guided by our vision “Health for all, hunger for none”, we promote inclusive growth and responsible use of resources. Entirely in line with our corporate purpose “Science for a better life”, every single day we work on developing and providing high-quality products which help people to improve their lives.

With our innovative products, we at Bayer Pharma seek to achieve therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers. Bayer Pharma is active in the following therapeutic areas: eye diseases, women’s health, hematology, cardiovascular diseases, infectious diseases, cancers, pulmonary hypertension, men’s health and neurology.

Bayer employs about 1,450 people in Zurich, Basel and Muttenz.

Further information on: www.bayer.ch

Located in:
Zurich

Company:
Bayer

Bayer is a Life Science company with a more than 150-year history. Our 101,000 employees are passionately committed to people’s health care and nutrition all over the world and push ahead with research, development and innovation in these areas. Contributing to sustainable development is a core element of Bayer’s strategy and values. Guided by our vision “Health for all, hunger for none”, we promote inclusive growth and responsible use of resources. Entirely in line with our corporate purpose “Science for a better life”, every single day we work on developing and providing high-quality products which help people to improve their lives.

With our innovative products, we at Bayer Pharma seek to achieve therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers. Bayer Pharma is active in the following therapeutic areas: eye diseases, women’s health, hematology, cardiovascular diseases, infectious diseases, cancers, pulmonary hypertension, men’s health and neurology.

Bayer employs about 1,450 people in Zurich, Basel and Muttenz.

Further information on: www.bayer.ch

Located in:
Baar

Company:
Biogen

As a pioneer in neuroscience, Biogen researches, de­velops and markets innovative therapies worldwide for people with serious neurological diseases and in related therapeutic areas. Founded in Geneva in 1978 as one of the first global biotechnology companies, Biogen today has an extensive portfolio of medici­nes for multiple sclerosis, the first approved therapy for spinal muscular atrophy and markets biosimilars of advanced biologics. We are focused on advancing our research programmes in neuroscience that can change the standard of care in areas of high unmet need, such as Alzheimer‘s disease. Since 2004, Bio­gen has managed its operations from its international headquarters in Baar. In Switzerland, Biogen is also present with the state-of-the-art production facility in Luterbach, which enables large-scale production of biopharmaceuticals.

More information at: Home (biogen.ch)

Located in:
Luterbach

Company:
Biogen

As a pioneer in neuroscience, Biogen researches, de­velops and markets innovative therapies worldwide for people with serious neurological diseases and in related therapeutic areas. Founded in Geneva in 1978 as one of the first global biotechnology companies, Biogen today has an extensive portfolio of medici­nes for multiple sclerosis, the first approved therapy for spinal muscular atrophy and markets biosimilars of advanced biologics. We are focused on advancing our research programmes in neuroscience that can change the standard of care in areas of high unmet need, such as Alzheimer‘s disease. Since 2004, Bio­gen has managed its operations from its international headquarters in Baar. In Switzerland, Biogen is also present with the state-of-the-art production facility in Luterbach, which enables large-scale production of biopharmaceuticals.

More information at: Home (biogen.ch)

Located in:
Boudry

Company:
Bristol-Myers Squibb (BMS)

Bristol Myers Squibb is a leading global biopharma­ceutical company dedicated to discovering, develo­ping and delivering innovative medicines. The compa­ny helps millions of people worldwide in therapeutic areas such as oncology, haematology and immuno­logy, as well as cardiovascular disease. Bristol Myers Squibb has been present in the Swiss pharmaceutical market for over 60 years and is involved in internatio­nal research due to the importance of the location. In Switzerland, the company employs over 1 000 people in Steinhausen, Zofingen and Boudry. Bristol Myers Squibb was awarded as a Great Place to Work® in 2021 and 2022.

More information at: Bristol Myers Squibb

Located in:
Steinhausen

Company:
Bristol-Myers Squibb (BMS)

Bristol Myers Squibb is a leading global biopharma­ceutical company dedicated to discovering, develo­ping and delivering innovative medicines. The compa­ny helps millions of people worldwide in therapeutic areas such as oncology, haematology and immuno­logy, as well as cardiovascular disease. Bristol Myers Squibb has been present in the Swiss pharmaceutical market for over 60 years and is involved in internatio­nal research due to the importance of the location. In Switzerland, the company employs over 1 000 people in Steinhausen, Zofingen and Boudry. Bristol Myers Squibb was awarded as a Great Place to Work® in 2021 and 2022.

More information at: Bristol Myers Squibb

Located in:
Zofingen

Company:
Bristol-Myers Squibb (BMS)

Bristol Myers Squibb is a leading global biopharma­ceutical company dedicated to discovering, develo­ping and delivering innovative medicines. The compa­ny helps millions of people worldwide in therapeutic areas such as oncology, haematology and immuno­logy, as well as cardiovascular disease. Bristol Myers Squibb has been present in the Swiss pharmaceutical market for over 60 years and is involved in internatio­nal research due to the importance of the location. In Switzerland, the company employs over 1 000 people in Steinhausen, Zofingen and Boudry. Bristol Myers Squibb was awarded as a Great Place to Work® in 2021 and 2022.

More information at: Bristol Myers Squibb

Located in:
Basel

Company:
Boehringer Ingelheim

Boehringer Ingelheim works on breakthrough thera­pies that improve the lives of people and animals. Since its foundation in 1885, Boehringer Ingelheim has been family-owned and pursues a long-term per­spective. Around 52,000 employees serve more than 130 markets worldwide in three business areas: Hu­man Pharmaceuticals, Animal Health and Biophar­maceutical Contract Manufacturing. In Switzerland, Boehringer Ingelheim employs around 100 people in Human Pharmaceuticals and Animal Health. The fo­cus is on diseases for which there is yet no satisfacto­ry treatment option. In Human Pharmaceuticals, the main indications are cardiometabolic diseases, diabe­tes, respiratory diseases, oncology, diseases of the central nervous system and immunology. In Animal Health, Boehringer Ingelheim is a world leader in pre­vention through vaccines and antiparasitics.

More information at: Homepage | boehringer-ingelheim.ch

Located in:
Vernier

Company:
Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. We focus our research efforts primarily on our core therapeutic areas: Diabetes, Oncology, Immunology and Neuroscience. Lilly employs around 38,000 people worldwide and our medicines are marketed in 120 countries. Based in Geneva since 1959, Eli Lilly (Suisse) SA and Eli Lilly Export SA employ 160 people.

More information at: Home | Lilly Schweiz and Accueil | Lilly Suisse

Located in:
Zug

Company:
Gilead

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines for medical areas where there is a high unmet need. The company’s mission is to advance and simplify care for patients with life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in more than 35 countries worldwide. The company focuses on HIV, viral hepatitis, cancer, and COVID-19.

More information at: Switzerland | Gilead

Located in:
Münchenbuchsee

Company:
GlaxoSmithKline (GSK)

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

We have been operating in Switzerland since 2001 and employ around 120 people at our head office in Münchenbuchsee, Canton Bern. At or our branch office in Baar, Canton Zug some 50 employees are involved in various global positions within GSK in the therapeutic area of oncology.

More information at: Switzerland | GSK

Located in:
Baar

Company:
GlaxoSmithKline (GSK)

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

We have been operating in Switzerland since 2001 and employ around 120 people at our head office in Münchenbuchsee, Canton Bern. At or our branch office in Baar, Canton Zug some 50 employees are involved in various global positions within GSK in the therapeutic area of oncology.

More information at: Switzerland | GSK

Located in:
Allschwil

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Bern

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Zug

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Schaffhausen

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Glattbrugg

Company:
Lundbeck

Lundbeck (Schweiz) AG is the subsidiary of the Da­nish pharmaceutical company of the same name and has been in existence since 1948. Since 2016, the Swiss subsidiary has been located in the Zurich air­port area. Today, 70% of the Lundbeck company is owned by the Lundbeck Foundation, which was es­tablished in 1954. The Lundbeck Foundation awards around CHF 70 million in independent research fun­ding each year and also awards the world‘s largest Brain Prize. Each year, the Lundbeck Foundation awards approximately 1.3 million Swiss francs to one or more brain researchers who have made a ground­breaking contribution to neuroscience. The H. Lund­beck A /S company invests in research into new drugs to treat diseases of the central nervous system, with a focus on migraine, depression and schizophrenia. In addition to developing new and increasingly better drug therapies, we also advocate for those affected and their families and fight for social acceptance of people with brain diseases.

More information at: lundbeck.com

Located in:
Aubonne

Company:
Merck

Founded by Friedrich Jacob Merck in Darmstadt in 1668, Merck is the world‘s oldest pharmaceutical and chemical company. Over the course of 350 years, we have developed into a leading science and techno­logy company in the fields of healthcare, life sciences and performance materials. Our 56,000 employees share a passion for new ideas, technological opportu­nities, and the potential to make a difference around the world. From biopharmaceuticals for the treatment of cancer or multiple sclerosis, to cutting-edge sys­tems for scientific research and production, to liquid crystals for smartphones. Since the establishment of its first subsidiary in 1929, Merck has had a strong presence in Switzerland in the Healthcare and Life Sciences sectors. Specialised, high-quality products are manufactured in Switzerland and supplied all over the world. In total, Merck employs over 2,500 people at 8 sites in Aubonne, Corsier-sur-Vevey, Eysins, Zug, Altdorf, Schaffhausen and Buchs.

More information at: Merck | Switzerland | Life Science Products & Service Solutions (sigmaaldrich.com)

Located in:
Corsier-sur-Vevey

Company:
Merck

Founded by Friedrich Jacob Merck in Darmstadt in 1668, Merck is the world‘s oldest pharmaceutical and chemical company. Over the course of 350 years, we have developed into a leading science and techno­logy company in the fields of healthcare, life sciences and performance materials. Our 56,000 employees share a passion for new ideas, technological opportu­nities, and the potential to make a difference around the world. From biopharmaceuticals for the treatment of cancer or multiple sclerosis, to cutting-edge sys­tems for scientific research and production, to liquid crystals for smartphones. Since the establishment of its first subsidiary in 1929, Merck has had a strong presence in Switzerland in the Healthcare and Life Sciences sectors. Specialised, high-quality products are manufactured in Switzerland and supplied all over the world. In total, Merck employs over 2,500 people at 8 sites in Aubonne, Corsier-sur-Vevey, Eysins, Zug, Altdorf, Schaffhausen and Buchs.

More information at: Merck | Switzerland | Life Science Products & Service Solutions (sigmaaldrich.com)

Located in:
Eysins

Company:
Merck

Founded by Friedrich Jacob Merck in Darmstadt in 1668, Merck is the world‘s oldest pharmaceutical and chemical company. Over the course of 350 years, we have developed into a leading science and techno­logy company in the fields of healthcare, life sciences and performance materials. Our 56,000 employees share a passion for new ideas, technological opportu­nities, and the potential to make a difference around the world. From biopharmaceuticals for the treatment of cancer or multiple sclerosis, to cutting-edge sys­tems for scientific research and production, to liquid crystals for smartphones. Since the establishment of its first subsidiary in 1929, Merck has had a strong presence in Switzerland in the Healthcare and Life Sciences sectors. Specialised, high-quality products are manufactured in Switzerland and supplied all over the world. In total, Merck employs over 2,500 people at 8 sites in Aubonne, Corsier-sur-Vevey, Eysins, Zug, Altdorf, Schaffhausen and Buchs.

More information at: Merck | Switzerland | Life Science Products & Service Solutions (sigmaaldrich.com)

Located in:
Zug

Company:
Merck

Founded by Friedrich Jacob Merck in Darmstadt in 1668, Merck is the world‘s oldest pharmaceutical and chemical company. Over the course of 350 years, we have developed into a leading science and techno­logy company in the fields of healthcare, life sciences and performance materials. Our 56,000 employees share a passion for new ideas, technological opportu­nities, and the potential to make a difference around the world. From biopharmaceuticals for the treatment of cancer or multiple sclerosis, to cutting-edge sys­tems for scientific research and production, to liquid crystals for smartphones. Since the establishment of its first subsidiary in 1929, Merck has had a strong presence in Switzerland in the Healthcare and Life Sciences sectors. Specialised, high-quality products are manufactured in Switzerland and supplied all over the world. In total, Merck employs over 2,500 people at 8 sites in Aubonne, Corsier-sur-Vevey, Eysins, Zug, Altdorf, Schaffhausen and Buchs.

More information at: Merck | Switzerland | Life Science Products & Service Solutions (sigmaaldrich.com)

Located in:
Basel

Company:
Moderna

Biotech firm Moderna was established in Cambridge, Massachusetts, USA, in 2010, and has since been working towards building an industry-leading mRNA technology platform. Moderna opened its Swiss subsidiary and EMEA (Europe, Middle East and Africa) headquarters in Basel in September 2020. With the approval of the RNA vaccine against the SARS-CoV-2 virus, Moderna made a key contribution to fighting the pandemic. Moderna’s goal is to meet the expectations associated with mRNA research for a new generation of transformational medicines for patients. Moderna develops mRNA medications for various forms of administration and makes them available to patients around the world. Our work currently focuses on six medical fields: infectious diseases, immuno-oncology, rare diseases, autoimmune diseases, personalized cancer vaccines and cardiovascular diseases.

More information at: Pioneering mRNA technology – Moderna (modernatx.com)

Located in:
Lucerne, Citybay

Company:
MSD (Merck Sharp & Dohme)

MSD (Merck Sharp & Dohme) is a leading global biophar­maceutical company that has been developing medicines and vaccines for the most challenging diseases for more than a century. MSD Switzerland employs around 1,000 people in local, regional and global functions at four sites in the canton of Lucerne and one site in the canton of Zu­rich. Our business activities are divided into the two areas of human and veterinary medicine. In human medicine, research activities focus on oncology and vaccines. In the area of infectious diseases, MSD is also re-searching new therapeutic approaches for antibiotic resistance and HIV/ AIDS. Other research focuses are immunology and diabe­tes. In addition, MSD is committed to tackling major pub­lic health challenges such as Ebola and SARS-CoV-2. Sin­ce 2018, MSD has been operating a forensic laboratory in Schachen with the aim of detecting tampering and coun­terfeiting of our products, thereby making an important contribution to patient safety. MSD Switzerland has been continuously certified as a „Top Employer“ since 2013 and takes a pioneering position with its employee regulation for gender-neutral parental leave.

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Lucerne, Tribschen

Company:
MSD (Merck Sharp & Dohme)

MSD (Merck Sharp & Dohme) is a leading global biophar­maceutical company that has been developing medicines and vaccines for the most challenging diseases for more than a century. MSD Switzerland employs around 1,000 people in local, regional and global functions at four sites in the canton of Lucerne and one site in the canton of Zu­rich. Our business activities are divided into the two areas of human and veterinary medicine. In human medicine, research activities focus on oncology and vaccines. In the area of infectious diseases, MSD is also re-searching new therapeutic approaches for antibiotic resistance and HIV/ AIDS. Other research focuses are immunology and diabe­tes. In addition, MSD is committed to tackling major pub­lic health challenges such as Ebola and SARS-CoV-2. Sin­ce 2018, MSD has been operating a forensic laboratory in Schachen with the aim of detecting tampering and coun­terfeiting of our products, thereby making an important contribution to patient safety. MSD Switzerland has been continuously certified as a „Top Employer“ since 2013 and takes a pioneering position with its employee regulation for gender-neutral parental leave.

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Kriens

Company:
MSD (Merck Sharp & Dohme)

MSD (Merck Sharp & Dohme) is a leading global biophar­maceutical company that has been developing medicines and vaccines for the most challenging diseases for more than a century. MSD Switzerland employs around 1,000 people in local, regional and global functions at four sites in the canton of Lucerne and one site in the canton of Zu­rich. Our business activities are divided into the two areas of human and veterinary medicine. In human medicine, research activities focus on oncology and vaccines. In the area of infectious diseases, MSD is also re-searching new therapeutic approaches for antibiotic resistance and HIV/ AIDS. Other research focuses are immunology and diabe­tes. In addition, MSD is committed to tackling major pub­lic health challenges such as Ebola and SARS-CoV-2. Sin­ce 2018, MSD has been operating a forensic laboratory in Schachen with the aim of detecting tampering and coun­terfeiting of our products, thereby making an important contribution to patient safety. MSD Switzerland has been continuously certified as a „Top Employer“ since 2013 and takes a pioneering position with its employee regulation for gender-neutral parental leave.

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Schachen

Company:
MSD (Merck Sharp & Dohme)

MSD (Merck Sharp & Dohme) is a leading global biophar­maceutical company that has been developing medicines and vaccines for the most challenging diseases for more than a century. MSD Switzerland employs around 1,000 people in local, regional and global functions at four sites in the canton of Lucerne and one site in the canton of Zu­rich. Our business activities are divided into the two areas of human and veterinary medicine. In human medicine, research activities focus on oncology and vaccines. In the area of infectious diseases, MSD is also re-searching new therapeutic approaches for antibiotic resistance and HIV/ AIDS. Other research focuses are immunology and diabe­tes. In addition, MSD is committed to tackling major pub­lic health challenges such as Ebola and SARS-CoV-2. Sin­ce 2018, MSD has been operating a forensic laboratory in Schachen with the aim of detecting tampering and coun­terfeiting of our products, thereby making an important contribution to patient safety. MSD Switzerland has been continuously certified as a „Top Employer“ since 2013 and takes a pioneering position with its employee regulation for gender-neutral parental leave.

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Zurich

Company:
MSD (Merck Sharp & Dohme)

MSD (Merck Sharp & Dohme) is a leading global biophar­maceutical company that has been developing medicines and vaccines for the most challenging diseases for more than a century. MSD Switzerland employs around 1,000 people in local, regional and global functions at four sites in the canton of Lucerne and one site in the canton of Zu­rich. Our business activities are divided into the two areas of human and veterinary medicine. In human medicine, research activities focus on oncology and vaccines. In the area of infectious diseases, MSD is also re-searching new therapeutic approaches for antibiotic resistance and HIV/ AIDS. Other research focuses are immunology and diabe­tes. In addition, MSD is committed to tackling major pub­lic health challenges such as Ebola and SARS-CoV-2. Sin­ce 2018, MSD has been operating a forensic laboratory in Schachen with the aim of detecting tampering and coun­terfeiting of our products, thereby making an important contribution to patient safety. MSD Switzerland has been continuously certified as a „Top Employer“ since 2013 and takes a pioneering position with its employee regulation for gender-neutral parental leave.

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Basel

Company:
Novartis

Novartis is a global company with Swiss roots that go back more than 250 years. As a leading global pharmaceutical company, we use scientific innova­tion and digital technologies to develop breakthrough therapies in areas of unmet medical need. Novartis operates in more than 140 countries and is headquar­tered in Basel, Switzerland. Approximately 108 500 people work for Novartis worldwide, of which about 11,600 are employed in Switzerland. Novartis has seven sites in Switzerland: Basel BS, Schweizerhalle BL, Stein AG, Freiburg FR, Geneva GE, Locarno TI, and Rotkreuz ZG. The Novartis Campus in Basel is one of our most important research sites: Scientists from all over the world research novel medicines and therapies here.

More information at: Home | Novartis Schweiz

Located in:
Freiburg

Company:
Novartis

Novartis is a global company with Swiss roots that go back more than 250 years. As a leading global pharmaceutical company, we use scientific innova­tion and digital technologies to develop breakthrough therapies in areas of unmet medical need. Novartis operates in more than 140 countries and is headquar­tered in Basel, Switzerland. Approximately 108 500 people work for Novartis worldwide, of which about 11,600 are employed in Switzerland. Novartis has seven sites in Switzerland: Basel BS, Schweizerhalle BL, Stein AG, Freiburg FR, Geneva GE, Locarno TI, and Rotkreuz ZG.

More information at: Home | Novartis Schweiz

Located in:
Geneva

Company:
Novartis

Novartis is a global company with Swiss roots that go back more than 250 years. As a leading global pharmaceutical company, we use scientific innova­tion and digital technologies to develop breakthrough therapies in areas of unmet medical need. Novartis operates in more than 140 countries and is headquar­tered in Basel, Switzerland. Approximately 108 500 people work for Novartis worldwide, of which about 11,600 are employed in Switzerland. Novartis has seven sites in Switzerland: Basel BS, Schweizerhalle BL, Stein AG, Freiburg FR, Geneva GE, Locarno TI, and Rotkreuz ZG.

More information at: Home | Novartis Schweiz

Located in:
Locarno

Company:
Novartis

Novartis is a global company with Swiss roots that go back more than 250 years. As a leading global pharmaceutical company, we use scientific innova­tion and digital technologies to develop breakthrough therapies in areas of unmet medical need. Novartis operates in more than 140 countries and is headquar­tered in Basel, Switzerland. Approximately 108 500 people work for Novartis worldwide, of which about 11,600 are employed in Switzerland. Novartis has seven sites in Switzerland: Basel BS, Schweizerhalle BL, Stein AG, Freiburg FR, Geneva GE, Locarno TI, and Rotkreuz ZG.

More information at: Home | Novartis Schweiz

Located in:
Rotkreuz

Company:
Novartis Pharma Switzerland

Novartis Pharma Switzerland is a subsidiary of the international Novartis Group. At the Rotkreuz site, the company shares a modern office building with Sandoz, the generics and biosimilars division of Novartis. The approximately 260 employees of this business unit commercialise the approximately 80 prescription medicines of the Novartis Group in Switzerland. The most important therapeutic areas include oncology, hematology, neurology, immunology, and cardiology.

More information at: Novartis Pharma Schweiz | Novartis Schweiz

Located in:
Schweizerhalle BL

Company:
Novartis

Novartis is a global company with Swiss roots that go back more than 250 years. As a leading global pharmaceutical company, we use scientific innova­tion and digital technologies to develop breakthrough therapies in areas of unmet medical need. Novartis operates in more than 140 countries and is headquar­tered in Basel, Switzerland. Approximately 108 500 people work for Novartis worldwide, of which about 11,600 are employed in Switzerland. Novartis has seven sites in Switzerland: Basel BS, Schweizerhalle BL, Stein AG, Freiburg FR, Geneva GE, Locarno TI, and Rotkreuz ZG.

More information at: Home | Novartis Schweiz

Located in:
Stein

Company:
Novartis

Novartis is a global company with Swiss roots that go back more than 250 years. As a leading global pharmaceutical company, we use scientific innova­tion and digital technologies to develop breakthrough therapies in areas of unmet medical need. Novartis operates in more than 140 countries and is headquar­tered in Basel, Switzerland. Approximately 108 500 people work for Novartis worldwide, of which about 11,600 are employed in Switzerland. Novartis has seven sites in Switzerland: Basel BS, Schweizerhalle BL, Stein AG, Freiburg FR, Geneva GE, Locarno TI, and Rotkreuz ZG.

More information at: Home | Novartis Schweiz

Located in:
Zurich

Company:
Novo Nordisk

Novo Nordisk is a leading global pharmaceutical company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We have been doing this for 100 years through pioneering work, researching innovative solutions to prevent and cure diseases. We promote access to our products for patients around the world and are actively committed to prevention. With our Circular for Zero environmental strategy, we are pursuing a goal as a sustainable company to achieve zero environmental impact in all our business activities. We are the first pharmaceutical company to be using 100% renewable power in all our global production facilities since 2020. Novo Nordisk employs about 53,000 people in 80 countries and markets its products in around 170 countries. The first branch outside Denmark was established in 1930, in Switzerland. Today, there are around 250 employees working at the Zurich Airport site, about a third of whom work for the Swiss branch.

More information (in German): Novo Nordisk Pharma Ltd

© Flughafen Zürich AG

Located in:
Zurich

Company:
Pfizer

At Pfizer, we are committed to „breakthroughs that change patients‘ lives“ and have been successfully researching and developing innovative medicines and vaccines to treat or prevent disease for over 170 years. Pfizer is one of the world‘s leading biopharmaceutical companies, headquartered in Manhattan, New York, with approximately 80,000 colleagues worldwide. Pfizer has been based in Zürich, Switzerland, since 1959 and makes an important contribution to the provision of medicines to the local population. Pfizer distributes over 120 mainly prescription medicines throughout Switzerland.

More information at: Startseite | Pfizer Switzerland

Located in:
Basel

Company:
Roche

Roche is the world‘s largest biotechnology compa­ny and a global leader in in vitro diagnostics. Roche is a pioneer in personalised healthcare, combining strengths in diagnostics and pharmaceuticals with in­sights from clinical practice data to improve health­care around the world. Headquartered in Basel, the Roche Group operates in over 100 countries and em­ployed more than 100,000 people worldwide in 2021. Basel/Kaiseraugst is one of the world‘s largest sites with 11 000 employees from over 90 nations. It is home not only to the Executive Board, but also to all global functions. Roche Pharma (Switzerland) Ltd in Basel, with its 170 employees, is responsible for Marketing & Sales, Medical Affairs as well as Regis­tration and Quality Assurance of Roche‘s medicines in Switzerland. Roche is also one of the larger training companies in Switzerland, with 430 trainees in 14 dif­ferent professions.

More information at: Roche Switzerland

Located in:
Kaiseraugst

Company:
Roche

Roche is the world‘s largest biotechnology compa­ny and a global leader in in vitro diagnostics. Roche is a pioneer in personalised healthcare, combining strengths in diagnostics and pharmaceuticals with in­sights from clinical practice data to improve health­care around the world. Headquartered in Basel, the Roche Group operates in over 100 countries and em­ployed more than 100,000 people worldwide in 2021. Basel/Kaiseraugst is one of the world‘s largest sites with 11 000 employees from over 90 nations. It is home not only to the Executive Board, but also to all global functions. Roche is also one of the larger training companies in Switzerland, with 430 trainees in 14 dif­ferent professions.

More information at: Roche Switzerland

Located in:
Rotkreuz

Company:
Roche Diagnostics International Ltd

Roche Diagnostics International Ltd in Rotkreuz ZG was founded in 1969 and is today a leading global provider of diagnostic system solutions. With around 2,800 employees from over 70 nations, the company is the largest private employer in the canton of Zug. The site is part of the Roche Group and combines the central business areas and functions of the Diagno­stics Division. Innovative tests and systems for the rapid and reliable diagnosis of diseases are developed here. The company is also the largest manufacturer of fully automated, integrated in vitro diagnostic sys­tems in Switzerland. The EMEA/LATAM sales organi­sation and the Swiss sales teams of Roche Diagnostics and Roche Diabetes Care are also located at the site.

More information at: Roche Diagnostics

Located in:
Schlieren

Company:
Roche

Roche Innovation Center Zurich is Roche Pharma Research and Early Development’s (pRED) Center of Excellence for Cancer Immunotherapy. One major focus is the development of engineered antibodies that address unmet clinical needs. Roche Innovation Center Zurich is one of Roche’s antibody engineering powerhouses.
Glycart Biotechnology AG was initially established in September 2000 as a spin-off of the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. In the summer of 2005, it was acquired by the Roche Group and integrated in Roche Pharma Research and Early Development (pRED).

More information at: Roche Switzerland

Located in:
Rotkreuz

Company:
Sanofi

Sanofi is an innovative global healthcare company with a mission to “chase the miracles of science to improve people’s lives”. Worldwide, 100,000 employees are committed to transforming medicine. In Switzerland, Sanofi is organized into four business units with more than 200 employees in Rotkreuz and Vernier: Specialty Care (immunology, oncology, rare diseases, multiple sclerosis), Vaccines, General Medicines (diabetes, cardiovascular, atherothrombosis/thrombosis) and Consumer Healthcare (over-the-counter medicines).

More information at: Sanofi Schweiz

Located in:
Vernier

Company:
Sanofi

Sanofi is an innovative global healthcare company with a mission to “chase the miracles of science to improve people’s lives”. Worldwide, 100,000 employees are committed to transforming medicine. In Switzerland, Sanofi is organized into four business units with more than 200 employees in Rotkreuz and Vernier: Specialty Care (immunology, oncology, rare diseases, multiple sclerosis), Vaccines, General Medicines (diabetes, cardiovascular, atherothrombosis/thrombosis) and Consumer Healthcare (over-the-counter medicines).

More information at: Sanofi Schweiz

Located in:
Neuchâtel

Company:
Takeda

Founded in Japan in 1781, Takeda is now a leading global, value-driven, research-based biopharmaceu­tical company. In around 80 countries worldwide, more than 50,000 employees are committed to im­proving patients‘ quality of life and working with all healthcare partners.

Takeda entered the Swiss market in 1986 under the name Takeda Pharma AG. Since January 2020, Take­da Switzerland has been located in Glattpark, Zurich, together with the headquarters for Europe and Ca­nada. In total, more than 1000 employees are based at this site. The focus of Takeda Switzerland and its approximately 90 employees is on the approval and distribution of medicinal products for the Swiss mar­ket. A further 600 employees at the production site in Neuchâtel manufacture recombinant blood clotting factors for the global market. In 2022, Takeda was certified as a Top Employer in Switzerland for the se­cond time in a row.

More information at: Takeda In der Schweiz

Located in:
Zurich

Company:
Takeda

Founded in Japan in 1781, Takeda is now a leading global, value-driven, research-based biopharmaceu­tical company. In around 80 countries worldwide, more than 50,000 employees are committed to im­proving patients‘ quality of life and working with all healthcare partners.

Takeda entered the Swiss market in 1986 under the name Takeda Pharma AG. Since January 2020, Take­da Switzerland has been located in Glattpark, Zurich, together with the headquarters for Europe and Ca­nada. In total, more than 1000 employees are based at this site. The focus of Takeda Switzerland and its approximately 90 employees is on the approval and distribution of medicinal products for the Swiss mar­ket. A further 600 employees at the production site in Neuchâtel manufacture recombinant blood clotting factors for the global market. In 2022, Takeda was certified as a Top Employer in Switzerland for the se­cond time in a row.

More information at: Takeda In der Schweiz

Located in:
Bulle

Company:
UCB

UCB is a global biopharmaceutical company specialising in immunology and neurology. UCB is headquar­tered in Brussels (Belgium) and employs more than 8 700 people in over 40 countries, including around 600 qualified employees in Switzerland. Since 1996, UCB has invested more than 600 million Swiss francs in the construction and installation of state-of-the-art industrial facilities at its site in Bulle (canton of Fribourg). The UCB affiliate in Bulle helps to improve the lives of thousands of people around the world suffering from serious diseases. In terms of fairness, it is the first pharmaceutical company in Switzerland to be Equal Salary certified for equal pay between men and women.

More information at: UCB Schweiz

Standort:
EPFL (Lausanne)

Unternehmen:
Merck

Founded by Friedrich Jacob Merck in Darmstadt in 1668, Merck is the world‘s oldest pharmaceutical and chemical company. Over the course of 350 years, we have developed into a leading science and techno­logy company in the fields of healthcare, life sciences and performance materials. Our 56,000 employees share a passion for new ideas, technological opportu­nities, and the potential to make a difference around the world. From biopharmaceuticals for the treatment of cancer or multiple sclerosis, to cutting-edge sys­tems for scientific research and production, to liquid crystals for smartphones. Since the establishment of its first subsidiary in 1929, Merck has had a strong presence in Switzerland in the Healthcare and Life Sciences sectors. Specialised, high-quality products are manufactured in Switzerland and supplied all over the world. In total, Merck employs over 2,500 people at 8 sites in Aubonne, Corsier-sur-Vevey, Eysins, Zug, Altdorf, Schaffhausen and Buchs.

More information at: Merck | Switzerland | Life Science Products & Service Solutions (sigmaaldrich.com)